Skip to main content
RESTART LIFE SCIENCES logo

RESTART LIFE SCIENCES — Investor Relations & Filings

Ticker · HEAL CSE Manufacturing
Open in API
Filings indexed 204 across all filing types
Latest filing 2026-04-25 Regulatory Filings
Country CA Canada
Listing CSE HEAL

About RESTART LIFE SCIENCES

https://restartlife.co/

Restart Life Sciences Corp. is a life sciences company focused on the research, development, and delivery of innovative wellness solutions designed to address contemporary health and lifestyle challenges. The company utilizes science and technology to advance well-being, with a strategic emphasis on nutritional health and natural remedies. Its portfolio includes brands such as BrainBalls and BrainQ. Furthermore, the company is expanding its focus on gut health and better-for-you food products through the acquisition of the Holy Crap Foods portfolio of brands, integrating advanced food technology into its core business activities.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV1 “Certification of annual filings – venture issuer basic certificate” filed under Canadian NI 52-109. It is a compliance certificate by the CEO attesting to the annual filings, not the actual Annual Report or MD&A contents, nor an announcement of report publication. It is a regulatory filing with prescribed form content, fitting the fallback category for miscellaneous regulatory submissions. Therefore, it is classified as Regulatory Filings (RNS).
2026-04-25 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is Form 52-109FV1 – a certification by the CEO of a venture issuer regarding its annual filings under Canadian NI 52-109. It is neither the full annual report (10-K), an audit report (AR), nor any earnings, dividend, or capital transaction notice. It does not announce management changes, voting results, or other specific events. This type of compliance certificate is a mandatory regulatory submission that does not fit any more specific category, so it falls under the general Regulatory Filings (RNS) category.
2026-04-25 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
M&A Activity Classification · 1% confidence The document is an "Arrangement Agreement" dated April 16, 2026 between a REIT and multiple acquisition entities. It outlines the terms of a corporate arrangement under sections of the CBCA involving intermediary steps like a court order, meeting of unitholders, plan of arrangement, voting support agreements, and related conditions. It is clearly a merger/acquisition contract, not an annual or interim report, earnings release, or proxy solicitation. This type of full legal agreement detailing an M&A transaction falls squarely under M&A Activity (Code: TAR).
2026-04-25 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is a standalone Management’s Discussion and Analysis (“MD&A”) covering the years ended December 31, 2025 and 2024, describing operations, financial position, corporate highlights, outlook, and overall performance. It is not the full annual report itself (10-K), but the MD&A section, which falls under Management Reports (MDA).
2026-04-25 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is the Management’s Discussion and Analysis (MD&A) for the years ended December 31, 2025 and 2024. It provides management’s review of operations, financial position, results, business strategy, outlook, and detailed trends, consistent with the definition of a Management Report. It is not a full annual report or earnings release but is the standalone MD&A section typically filed with audited financial statements. Therefore, the correct classification is MDA (Management Reports).
2026-04-25 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 0% confidence The document is a Canadian securities commission Form 13-501F1 management certification for participation fee calculation under Alberta Securities Commission rules. It is not an annual or interim report, earnings release, or other predefined category. It serves as a regulatory filing for fee submission. Therefore, it falls into the fallback category: Regulatory Filings (RNS).
2026-04-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.